unknown
Stage
About
DioTree develops a first-in-class small molecule targeting the DIO3 enzyme to treat ovarian cancer.
Explore DioTree's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
DioTree develops a first-in-class small molecule targeting the DIO3 enzyme to treat ovarian cancer.
Funding rounds, investor list, and risk signals — unlock with a subscription.